Skip to main content
  • Business
      |Business
    • Business Intelligence
    • Compensation
    • Economics
    • Leadership
    • Legal News
    • Management
    • Mergers & Acquisitions
    • Policy & Regulations
    • Professional Associations
    • Staffing
    • Supply Chain
  • Care
      |Care
    • Care Delivery
    • Covid-19
    • Digital Transformation
    • Telehealth
  • Data
      |Data
    • Artificial Intelligence
    • Cybersecurity
    • EMR/EHR
    • Informatics
  • Videos
  • Conferences
      |Conferences
    • AHA
    • AMA
    • CHIME
    • HFMA
    • HIMSS
    • MGMA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe

Search form

Home

News You Need to Know Today
AI news that drew views this week (March 1-5)
Saturday, March 6, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

8 principles for AI ethics in pathology, other specialties

Clinical laboratories store a motherlode of objective and structured patient data well primed for mining with AI. Given this reality, pathologists and medical laboratorians must set and abide by principles guiding the ethical use of the technology.

READ MORE >
Researchers found the reason radiation and anthracyclines in some patients causes cardio toxicity may be due to the cGAS–STING pathway. This holds great potential as a treatment to prevent cardiac complications of DNA-damaging cancer treatments in new cardio-oncology research. Pathology Laboratory
Share on Twitter Share on Facebook Share on Linkedin

8 principles for AI ethics in pathology, other specialties

Share on Twitter Share on Facebook Share on Linkedin
Researchers found the reason radiation and anthracyclines in some patients causes cardio toxicity may be due to the cGAS–STING pathway. This holds great potential as a treatment to prevent cardiac complications of DNA-damaging cancer treatments in new cardio-oncology research. Pathology Laboratory
Clinical laboratories store a motherlode of objective and structured patient data well primed for mining with AI. Given this reality, pathologists and medical laboratorians must set and abide by principles guiding the ethical use of the technology.
READ MORE >

Nabla Logo ●  Fellow

AI finds pre-diabetes using only age, waist size—and Darwinism

Researchers in Italy have demonstrated a no-cost, AI-based technique for detecting the presence of previously undiagnosed abnormalities in blood sugar stability.

READ MORE >
Belt Tightening
Share on Twitter Share on Facebook Share on Linkedin

AI finds pre-diabetes using only age, waist size—and Darwinism

Share on Twitter Share on Facebook Share on Linkedin
Belt Tightening
Researchers in Italy have demonstrated a no-cost, AI-based technique for detecting the presence of previously undiagnosed abnormalities in blood sugar stability.
READ MORE >

IBM sale of Watson Health reveals healthcare’s AI conflict

The reported exploration to sell Watson Health, the AI-driven health business of IBM, underscores deep challenges with technology in solving healthcare problems, according to the Wall Street Journal.

 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

IBM sale of Watson Health reveals healthcare’s AI conflict

Share on Twitter Share on Facebook Share on Linkedin
The reported exploration to sell Watson Health, the AI-driven health business of IBM, underscores deep challenges with technology in solving healthcare problems, according to the Wall Street Journal.  
READ MORE >

AI-powered voice screening for COVID earns CE mark

An Israeli AI startup has been cleared to market COVID-detecting voice analysis software in Europe, according to No Camels.

READ MORE >
Voice Recognition Smartphone
Share on Twitter Share on Facebook Share on Linkedin

AI-powered voice screening for COVID earns CE mark

Share on Twitter Share on Facebook Share on Linkedin
Voice Recognition Smartphone
An Israeli AI startup has been cleared to market COVID-detecting voice analysis software in Europe, according to No Camels.
READ MORE >

AI picks out blood biomarkers for autism

If verified in additional trials, the advance will facilitate care planning much earlier than the current average age of diagnosis, 4 years old.

READ MORE >
Special needs child
Share on Twitter Share on Facebook Share on Linkedin

AI picks out blood biomarkers for autism

Share on Twitter Share on Facebook Share on Linkedin
Special needs child
If verified in additional trials, the advance will facilitate care planning much earlier than the current average age of diagnosis, 4 years old.
READ MORE >

Featured Articles

Robots almost as good as clinicians at pleasing patients in the ER

Emergency-room patients are happy to receive care from a physician interacting remotely over a tablet computer mounted on a dog-like robot.

READ MORE >
Robot Dog
Share on Twitter Share on Facebook Share on Linkedin

Robots almost as good as clinicians at pleasing patients in the ER

Share on Twitter Share on Facebook Share on Linkedin
Robot Dog
Emergency-room patients are happy to receive care from a physician interacting remotely over a tablet computer mounted on a dog-like robot.
READ MORE >

AI imaging interpreter gains FDA’s OK for prostate care

The FDA has cleared an AI tool that helps radiologists diagnose or rule out prostate cancer on MRI scans.

READ MORE >
Prostate Cancer
Share on Twitter Share on Facebook Share on Linkedin

AI imaging interpreter gains FDA’s OK for prostate care

Share on Twitter Share on Facebook Share on Linkedin
Prostate Cancer
The FDA has cleared an AI tool that helps radiologists diagnose or rule out prostate cancer on MRI scans.
READ MORE >

AI identifies FDA-approved drugs warranting novel testing against Alzheimer’s

Harvard researchers have used machine learning to find molecular features in existing drugs that may be effective in warding off or treating Alzheimer’s disease.

READ MORE >
Chemist
Share on Twitter Share on Facebook Share on Linkedin

AI identifies FDA-approved drugs warranting novel testing against Alzheimer’s

Share on Twitter Share on Facebook Share on Linkedin
Chemist
Harvard researchers have used machine learning to find molecular features in existing drugs that may be effective in warding off or treating Alzheimer’s disease.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

BlueShield data breach exposes 4.7M patients | Optum taps new CEO | Alabama patients sue over stalled medical cannabis program
Economy: HHS budget leak | FTC vs PBMs on hold | PE bankruptcy report | Rural provider erosion | 44% of U.S. underinsured
Supreme Court votes 7-2 with HHS in hospital payment dispute | Warren fears ‘pharmacy deserts’ as PE buys Walgreens
Ad agency view of healthcare AI | Partner voice | Bill Gates, structured timelines, China tariffs, more
Report: Trump tariffs to raise drug prices 12.9% | 5.6M records exposed in Yale cyberattack
Mangione pleads ‘not guilty' as federal trial moves forward | HHS and RFK sued again over $11B public health cuts | more
Weekly Update: FDA emergency alerts | DeSantis in $10M Medicaid scandal | UPS expands healthcare wing | Walgreens fined $300M

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …65
    • Page 66
    • Page 67
    • Page 68
    • Current page 69
    • Page 70
    • Page 71
    • Page 72
    • Page 73 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme